Andrej Minich’s Post

Explore the past, present, and future of biomonitoring in Croatia and its comparison across Europe with the latest publication from the EDIAQI project. The study reveals how age, lifestyle factors, geographical locations, and weather conditions are potentially associated with genome damage caused by indoor as well as outdoor air pollutants. 👩🔬 EDIAQI proudly continues to provide baseline values for further biomonitoring studies, laying a solid foundation for future research as well as policy development. https://lnkd.in/eme-89HC #IAQ #EDIAQI #Biomonitoring #GenomeStability #HorizonEurope Goran Gajski

#MachineLearning requires copious amounts of data to be truly useful, and that’s especially true for important applications like #diagnostics and #drugdiscovery, so we’re putting our 30 years of collecting #biospecimens and clinical data to good use. Read about how researchers are capitalizing on our #biobank database to discover patterns and relationships relevant to both disease etiology and pathology in this article from Drug Target Review's Beyond the Lab Report on #AI: https://lnkd.in/dzCM2K_J

Probably the most important research progress ever in #endometriosis: global collaboration enables the collection of #bigdata to provide answers to improve diagnosis and management of #endo for millions, who suffer every day. A big #thankyou to everyone who have contributed their time, data, and wisdom through #EPHect to enhance our global knowledge and understanding about #endometriosis!

📢 We are pleased to share that our CEO and Founder, Marko Bitenc, spoke at the very first RAST conference https://lnkd.in/d7pHR5wf, under the segment "Innovations and Technologies in Medicine". He shared #GenePlanet's journey and a vision "5 years, 50 profitable markets" 📈 showcasing the impact of #pharmacogenomics and #genetics in advancing medical technologies. This pioneering conference, organized by Časnik Finance d.o.o., highlighted the crucial role of standards and continual innovation in enhancing the global competitiveness of Slovenian enterprises. 🌐 #GenePlanet #Genetics #HealthTech #Medicine #Innovation #Standards

📢 Save the date! 🌟 Join us for an engaging discussion facilitated by Agboola Micheal, a community member of the Data Scientists Network at the University of Ilorin. 🧪 🗓️ Event: Accelerating Drug Discovery for Pulmonary Fibrosis - The PulmoTech Project 🌐 Date: Monday, January 15, 2024 ⏰ Time: 8:00 PM - 10:00 PM (GMT+1) 🔍 Dive into the world of drug discovery for Pulmonary Fibrosis and explore the groundbreaking PulmoTech Project with Michael Agboola as your guide! 🌟 Key Discussion Points: ✅ Understanding Pulmonary Fibrosis and its impact ✅ Leveraging data science and AI in drug discovery ✅ Exploring the PulmoTech Project's innovative approach ✅ Collaboration opportunities and future prospects 👨💼 Get ready to be inspired and gain valuable insights into accelerating drug discovery for Pulmonary Fibrosis. 📝 Limited slots available! Register now to secure your spot here: https://lnkd.in/dhsHhuXJ. Don't miss this opportunity to be part of this enlightening discussion. 🔁 Spread the word and tag your friends who are interested in healthcare innovation and drug discovery. Let's come together to shape the future of Pulmonary Fibrosis treatment! #DrugDiscovery #PulmonaryFibrosis #DataScience #DSNUnilorin

Cordyceps militaris, a medicinal mushroom steeped in history, has emerged as a fascinating subject of scientific exploration due to its diverse biofunctionalities. 𝘉𝘪𝘰𝘧𝘶𝘯𝘤𝘵𝘪𝘰𝘯𝘢𝘭 𝘊𝘰𝘮𝘱𝘰𝘯𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘗𝘩𝘢𝘳𝘮𝘢𝘤𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘚𝘪𝘨𝘯𝘪𝘧𝘪𝘤𝘢𝘯𝘤𝘦: At the heart of Cordyceps militaris lies a treasure trove of biologically essential components, notably polysaccharides and others. The intricate blend of these compounds fuels the mushroom's pharmacological significance, sparking heightened interest in scientific literature. 𝘙𝘪𝘴𝘪𝘯𝘨 𝘎𝘭𝘰𝘣𝘢𝘭 𝘋𝘦𝘮𝘢𝘯𝘥 𝘢𝘯𝘥 𝘐𝘯𝘤𝘳𝘦𝘢𝘴𝘦𝘥 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘍𝘰𝘤𝘶𝘴: As global demand for natural remedies continues to surge, the research landscape on Cordyceps militaris has experienced a significant upswing. This trend underscores the mushroom's growing reputation as a medicinal powerhouse with multifaceted benefits. 𝘐𝘯𝘩𝘪𝘣𝘪𝘵𝘪𝘯𝘨 𝘐𝘯𝘧𝘭𝘢𝘮𝘮𝘢𝘵𝘪𝘰𝘯: Inflammation, a complex biological process intricately linked to the development of various diseases, stands as a primary target for Cordyceps militaris. Both in vivo and in vitro experiments have illuminated its potential in inhibiting inflammation-related events, showcasing its versatility in addressing conditions ranging from cancer to colitis and allergies. 𝘙𝘦𝘨𝘶𝘭𝘢𝘵𝘪𝘯𝘨 𝘗𝘳𝘰𝘪𝘯𝘧𝘭𝘢𝘮𝘮𝘢𝘵𝘰𝘳𝘺 𝘊𝘺𝘵𝘰𝘬𝘪𝘯𝘦𝘴: Cordyceps militaris demonstrates its efficacy as a functional food by regulating proinflammatory cytokines. This nuanced approach positions it as a potential ally in modulating inflammatory responses, presenting a compelling case for its integration into therapeutic strategies. Azoth Biotech invites you to be part of this exciting journey into the heart of nature's remedies. Collaborate with us, explore the possibilities, and contribute to the transformative impact that Cordyceps militaris holds for the future of healthcare. #CordycepsMilitaris #NaturalRemedies #Biofunctionalities #MedicinalMushroom #HealthcareInnovation #InflammationControl #AzothPost #BiotechResearch #TherapeuticPotential #FunctionalFoods #ScientificExploration #NatureHeals #ResearchFocus #GlobalHealth #Polysaccharides #AzothBiotech #CytokineRegulation #HolisticHealth #MushroomMedicine #HealthRevolution #NatureIsMedicine #CollaborateForHealth #ExploreNature #Biological

Did you know that the use of "DNA passes" – a credit card-sized card with crucial genetic information – can assist in tailoring drug treatments to individual genetic profiles, cutting serious adverse reactions by 30%? This innovation, developed by researchers from Karolinska Institutet and Leiden University Medical Center, could transform patient care and significantly reduce healthcare costs.   A study published in The Lancet, involving nearly 7,000 participants across Europe, supports this approach. It not only promises to enhance treatment efficacy but also addresses the EU's challenge of adverse drug reactions, responsible for up to 128,000 deaths yearly. The "DNA pass" enables precise drug dosage adjustments, marking a significant leap in personalised medicine.   As a note of interest, the term "DNA-pass" was recently added to the Swedish language by the Institute for Language and Folklore (Isof). This addition highlights the technology's growing importance in healthcare and society.   #DNApass #HealthcareInnovation #PersonalisedMedicine

𝐒𝐦𝐚𝐥𝐥 𝐛𝐮𝐭 𝐌𝐢𝐠𝐡𝐭𝐲: 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐌𝐢𝐜𝐫𝐨𝐑𝐍𝐀 𝐌𝐚𝐫𝐤𝐞𝐭'𝐬 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 The #future of #healthcare with the #MicroRNA Market – a #dynamic arena where tiny #molecules play a colossal role. This burgeoning field explores the transformative #potential of microRNA in revolutionizing #diagnostics and #therapeutics. Dive into a world of precision #medicine, where these small #RNA #molecules serve as powerful #biomarkers, enabling early #disease detection and paving the way for personalized #treatment strategies. Stay ahead of the curve as cutting-edge research, #clinical applications, and market #dynamics converge to reshape the landscape of #healthcare innovation. #MicroRNA #HealthcareRevolution 🔊𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 ❇Thermo Fisher Scientific, ❇QIAGEN ❇Horizon Discovery ❇NanoString Technologies, Inc. ❇Merck Group ❇Takara Bio USA, Inc. ❇LGC ❇BioGenex ❇GeneCopoeia, ❇New England Biolabs #MicroRNA #HealthcareInnovation #PrecisionMedicine #Biomarkers #Diagnostics #Therapeutics #ResearchBreakthroughs #PersonalizedMedicine #Biotech #MarketTrends #HealthTech #RegenerativeMedicine #ClinicalApplications #Genomics #FutureOfHealthcare

In the heart of #SoutheastAsia, Indonesia is part of a revolutionary shift: a genomics-based healthcare revolution that promises to create new opportunities and foster economic growth. 📹 Watch now: https://lnkd.in/gWtxQu8S While investments in genomics-related ventures were relatively novel in 2018, we have invested in leading #genomics startups as a clear demonstration of our unwavering belief. But our support does not stop there; we actively back initiatives that accelerate genomics research and innovation while collaborating with stakeholders. East Ventures and NalaGenetics are committed to supporting the genomic analysis of the Indonesian population at the Biomedical and Genome Science Initiative (BGSi). East Ventures extends sequencing support in the form of consumables valued at IDR 1,022,395,458. We believe that investing in genomics is an #investment for the future. East Ventures remains steadfast in its commitment to forge a #productive and healthy Southeast Asia for today, tomorrow, and more generations to come. #EastVentures #NalaGenetics #Genomics #BGSi #KemenkesRI #genomesequencing

ANOTHER SUCCESSFUL STUDY ON LIVESPO NAVAX PUBLISHED IN NATURE SCIENTIFIC REPORTS (official link below) 🌱 LiveSpo NAVAX Increases the Effectiveness of Treating Flu Symptoms by up to 58% This research was conducted by LiveSpo's R&D experts in collaboration with highly experienced researchers and doctors which has indicated that LiveSpo NAVAX supports a rapid and effective treatment of flu symptoms, specifically: 👉 Shortens recovery time and treatment by more than 2 days. 👉 Increases the effectiveness of symptom treatment by 58%. 👉 Effectively reduces flu virus load by over 26 times. 👉 Significantly decreases bacterial concentration by more than 65 times. Prior to this study, an article on the clinical trial of LiveSpo NAVAX in children with respiratory syncytial virus (RSV) was published in the Scientific Reports-Nature journal and was voted one of the top 100 downloaded articles in the field of microbiology in 2022. LiveSpo NAVAX (Nasal spray containing Bacillus probiotics) helps: 👉 Reduce RSV virus concentration by 600 times. 👉 Decrease flu virus concentration by 800 times. 👉 Achieve results 50 times more effective than saline solution. 📑 About Nature Scientific Reports: Scientific Reports is ranked among the top 10 most reputable multidisciplinary journals by SCImago based on its contributions to the scientific community. In 2016, Scientific Reports became the world's largest journal by publication volume. Furthermore, Springer Nature, the publisher, is one of the world's leading publishers in natural sciences and medicine. 👉 Read more: https://lnkd.in/gAw4bz5M 👉 For more information: https://lnkd.in/gv-Sh8Dx 📧 Contact us: hello@livespo.com #LiveSpo #LiveSpoNAVAX #Naturescientificreports #Nature #probiotics #liquidprobiotics #nasalspray #science #research #biotech